Tumours steal a signal from immune cells
Cancer cells are resourceful. They do not just compete for space and nutrients; they also hijack the molecular signals that immune cells use to communicate. A new paper in Science describes how tumours do this with T cells.
T cells are the frontline soldiers of the immune system. They recognise and destroy cancer cells. But inside many tumours, T cells become exhausted or are blocked from acting. The study, published in the journal Science, describes how tumours actively co-opt a signal from T cells to support their own survival. This goes beyond simply evading immune attack: the tumour uses the immune signal as a resource of its own.
How does signal hijacking work?
When T cells are active, they secrete certain molecules. These are normally meant to alert or activate other immune cells. Tumours appear to develop receptors that intercept those messages and exploit them, possibly to drive growth or build a protective environment. The paper provides evidence for this mechanism, though it is published as a short scientific commentary; full experimental details are available in the associated primary literature.
The idea that tumours exploit immune signals is not new, but this specific form, the literal interception of a communication molecule, adds a layer to our understanding of how cancer cells survive in hostile conditions.
Implications for therapy and aging
Immunotherapy works by strengthening T cells or releasing them from inhibitory signals. If tumours actively steal T cell signals, therapy design may also need to account for that hijacking process. This could help explain why some immunotherapies perform less well in practice than anticipated.
The link to aging is indirect but relevant. Immune aging (the declining efficiency of the immune system with age) makes T cells less effective. A weakened T cell response may give tumours more opportunity to exploit hijacking strategies. Preserving T cell function with age is therefore a related research direction worth watching.
Want to research this yourself?
Search terms: tumour immune evasion T cell signalling, immunotherapy resistance tumour microenvironment, T cell exhaustion cancer